AI in clinical trials presents key market opportunities by enhancing patient recruitment, optimizing trial designs, and automating tasks, thus reducing time and costs. Adoption is driven by the need ...

In December, the federal health department asked for feedback on how to boost the use of artificial intelligence for clinical ...

Upon validation, device developers will also have the opportunity to showcase their connected care technologies in the Oracle ...

Broyhill Asset Management, an investment advisor, released its fourth-quarter 2025 investor letter. A copy of the letter can ...

Oracle Health has launched a device validation program aimed at standardizing how medical devices connect to health systems and electronic health records. The company introduced the Oracle Health ...

Oracle Corp. has begun laying the groundwork needed to start construction on its new headquarters in Nashville.

The March 2026 issue of NEJM Catalyst Innovations in Care Delivery is a special theme issue on the hard work of implementing artificial intelligence in real-world ...

Meridian Funds, managed by ArrowMark Partners, released its fourth-quarter 2025 investor letter for “Meridian Small Cap ...

The AI tool drafts structured notes from patient-clinician interactions, helping to reduce administrative work.

With the clinical artificial intelligence agent, doctors are able to spend less time sifting through drop-down menus and typing on their laptops to document patient visits, the EHR company says.

LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new ...